Carbidopa-levodopa (Sinemet)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Neuroneeds review
Carbidopa-levodopa (Sinemet)
ATI class: Dopaminergic agent / Antiparkinson medication
Action
- ATI/source-folder candidate for Carbidopa-levodopa (Sinemet); verify mechanism against the source table before validation.
Therapeutic use
- Review under Neuromuscular Disorders medication safety.
Nursing assessment
- Assess rigidity, bradykinesia, tremor, mobility, and wearing-off patterns.
- Check orthostatic blood pressure and fall risk.
- Assess hallucinations, dyskinesia, and swallowing safety.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Dyskinesia
- Orthostatic hypotension
- Nausea
- Hallucinations
- Dark urine or sweat discoloration
Interactions
- High-protein meals can reduce levodopa absorption for some clients.
- Nonselective MAOIs can cause hypertensive crisis.
- Antipsychotics can reduce dopaminergic effect.
Contraindications
- Concurrent nonselective MAOI use
- Hypersensitivity
Precautions
- Use caution with psychosis, glaucoma, dysrhythmias, and melanoma history.
- Abrupt withdrawal can cause serious rigidity or fever-like syndrome.
Client teaching
- Take on schedule and do not skip or delay doses.
- Rise slowly and use fall precautions.
- Discuss protein timing if wearing-off or absorption problems occur.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Late Parkinson medication can look like sudden functional decline.
- Severe hallucinations or syncope needs review.
- Swallowing difficulty raises aspiration priority.
Medication classes
Source attribution
Google Drive source topic: Neuromuscular Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Med classmedication class
Dopaminergic agents
Boosts dopamine signaling to improve bradykinesia, rigidity, and tremor.
ATI cuePrecaution
Abrupt withdrawal can cause serious rigidity or fever-like syndrome.
ATI medication precaution concept.
ATI cueClass
Antiparkinson medication
ATI medication class concept.
ATI cueInteraction
Antipsychotics can reduce dopaminergic effect.
ATI medication interaction concept.
ATI cueNursing Assessment
Assess hallucinations, dyskinesia, and swallowing safety.
ATI medication nursing assessment concept.
ATI cueNursing Assessment
Assess rigidity, bradykinesia, tremor, mobility, and wearing-off patterns.
ATI medication nursing assessment concept.
ATI cueMechanism of Action
ATI/source-folder candidate for Carbidopa-levodopa (Sinemet); verify mechanism against the source table before validation.
ATI medication mechanism of action concept.
ATI cueNursing Assessment
Check orthostatic blood pressure and fall risk.
ATI medication nursing assessment concept.
ATI cueContraindication
Concurrent nonselective MAOI use
ATI medication contraindication concept.
ATI cueAdverse Effect
Dark urine or sweat discoloration
ATI medication adverse effect concept.
ATI cueClient Teaching
Discuss protein timing if wearing-off or absorption problems occur.
ATI medication client teaching concept.
ATI cueClass
Dopaminergic agent
ATI medication class concept.